title: [Neuropsychic side effects of bromocriptine in Parkinson's disease].
abstract: The clinical characteristics of psychiatric side effects of bromocriptine in patients with Parkinson's disease were studied in 12 cases. The clinical picture was characterized by hallucinations and delirium. Daily doses of bromocriptine (more than 30 mg daily), not duration of the disease or pretreatment with levodopa or previous psychiatric diseases, appeared to be the most important causal factor.
authors: Service de Neurologie, Centre Hospitalier Universitaire Purpan, Toulouse.
authors: M
authors: M
authors: Simonetta
authors: L
authors: L
authors: Schmitt
authors: J L
authors: JL
authors: Montastruc
authors: A
authors: A
authors: Rascol
mesh_terms: D000368:Aged; D001971:Bromocriptine / Q000008:administration & dosage / Q000009:adverse effects*; D003072:Cognition Disorders / Q000139:chemically induced*; D003702:Delusions / Q000139:chemically induced; D005260:Female; D006212:Hallucinations / Q000139:chemically induced; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000139:chemically induced*; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*
chemical_list: D001971:Bromocriptine
vernacular_title: Effets neuropsychiques secondaires de la bromocriptine dans la maladie de Parkinson.